Heart valve study pulled before it even started
NCT ID NCT04100720
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study planned to test a new device called the Cardiovalve for people with severe tricuspid regurgitation (a leaky heart valve). The goal was to see if the device could safely replace the valve and reduce leakage. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRICUSPID REGURGITATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Columbia University Medical Center / NYPH
New York, New York, 10032, United States
-
Montefiore Medical Center
The Bronx, New York, 10461, United States
-
Northwestern University / Bluhm Cardiovascular Institute
Chicago, Illinois, 60611, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A new Catheter-Based valve could fix a leaky heart valve without surgery
- New clip device aims to repair leaky heart valve without Open-Heart surgery
- New study aims to simplify care for patients with multiple leaky heart valves
- 5,500 patients to test new heart valve devices in massive safety study
- Heart valve repair devices under 5-Year safety spotlight
- Study aims to find best treatment for leaky heart valve in older adults